Jeffrey S. Cohen

Ladenburg Thalmann & Co., Inc. (Broker) is the broker/dealer division of Ladenburg Thalmann & Co., Inc., ultimately held by Advisor Group Holdings, Inc. Headquartered in New York City, the firm was founded in 1876 and offers a full suite of capital markets products and services, including proprietary equity research and a fixed-income trading desk. For institutional asset management clients, the firm provides liquidity, execution, high-quality idea-generating research, and access to corporate management teams. Their institutional coverage includes relationships with over asset management companies all over the world. To corporate clients, they bring access to investor capital, broad distribution capabilities and financial markets advisory. Ladenburg Thalmann is a leader in financing growing middle-market public companies across various industry verticals, including Healthcare & Life Sciences, Yield-Oriented Securities (BDCs, REITs, MLPs), Energy, Power & Infrastructure, and Telecom, Media & Technology.

Jesup & Lamont Securities Corp. is broker/dealer headquartered in New York City. The firm is a subsidiary of Jesup & Lamont, Inc. (AMEX: JLI), formerly Empire Financial Holding Co., a New York City-based full-service brokerage and investment banking firm that specializes in institutional, retail sales, trading services and equity research. Jesup & Lamont, Inc. was founded in 2000, but traces its roots to the 1877 partnership between James Jesup and Lansing Lamont. Jesup & Lamont Securities Corp. provides institutional and retail sales and trading services, equity research and asset management for institutions and high net-worth individuals. The firm's corporate finance activities include mergers and acquisitions, capital raising, acquisition finance, restructurings and other corporate finance matters. Their research covers the following areas in the US and abroad: biotechnology, industrials, specialty retail, aerospace/defense, alternative energy, oil & gas, restaurants, technology, transportation and special situations. Jesup & Lamont provides fundamental analysis of companies and sectors and also employs strategists and technical analysts to provide comprehensive research insights.

Cantor Fitzgerald Securities (CFS) is a financial services provider headquartered in New York City and was founded in 1945. They are a subsidiary of Cantor Fitzgerald LP and their ultimate parent is CF Group Management, Inc. CFS offers an array of financial products and services in the equity and fixed-income capital markets. The firm provides sales and trading, investment banking, asset management, market commentary and market data.

C.K. Cooper & Co. is a full-service investment banking and broker/dealer headquartered in Irvine, California. The firm was founded in 1982 as a wholly-owned subsidiary of C & K Capital Corp., and a sister company to Paladin Capital Partners, Inc. The services provided by C.K. Cooper & Co. were expanded in 1996, when a management team led by Alexander G. Montano purchased the firm. In 2001, C.K. Cooper & Co. began to offer brokerage services to individual investors. The firm is a member of the NASD. C.K. Cooper & Co. focuses on the oil and gas sectors. Their primary focus within the oil and gas sectors is the exploration and production sub-sector. The core thesis of the firm's research is based on what they refer to as the feeding frenzy, suggesting that there are constant business cycles within the E&P sector. These cycles are predicated on the need for larger oil and gas companies to acquire smaller exploration and production companies to maintain rates of growth.

Founded in 2007, BioLogic Investment Research LLC is an independent research firm located in Tallahassee, Florida. They focus on companies in the biotechnology, life sciences and medical devices sectors. The firm provides proprietary and self-initiated research for leading institutional investors. They seek to help their clients exploit the pervasive and repetitive informational inefficiencies inherent in the life sciences and healthcare capital markets including those arising from questionable corporate PR, dubious science and suspect medical literature. While BioLogic covers the full spectrum of life sciences companies, they focus on high-alpha binary events such as regulatory action dates and clinical data releases. In addition, BioLogic writes extensively on companies and products tainted by deception to outright fraud.